FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include REKELE. The owner is based in GUANGDONG PROVINCE.

503, 1ST FLOOR, BUILDING A, NO. 5 XIAHENG 1ST ROAD, SHAYONG, LISHUI TOWN, NANHAI DISTRICT, FOSHAN CITY

GUANGDONG PROVINCE 528000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REKELE
REKELE
Registered 2023

Trademark Classifications

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. have?

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. file in?

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD.'s most well-known trademarks?

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as REKELE. These are among 1 currently registered trademark in the portfolio.

What is FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD.'s trademark registration success rate?

FOSHAN ZIKE BEAUTY TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.